Skip to main content
SpringerLink
Log in

Managing urinary incontinence in women depends on whether symptoms are associated with stress, urgency or both

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21 (2): 167–78

    Article  PubMed  Google Scholar 

  2. Hashim H, Abrams P. Pharmacological management of women with mixed urinary incontinence. Drugs 2006; 66 (5): 591–606

    Article  PubMed  CAS  Google Scholar 

  3. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003 May; 20 (6): 327–36

    PubMed  CAS  Google Scholar 

  4. Coyne KS, Zhou Z, Thompson C, et al. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003 Nov; 92(7): 731–5

    Article  PubMed  CAS  Google Scholar 

  5. Monz B, Pons ME, Hampel C, et al. Patient-reported impact of urinary incontinence: results from treatment seeking women in 14 European countries. Maturitas 2005 Nov; 52 Suppl. 2: 24–34

    Article  Google Scholar 

  6. Hu TW, Wagner TH, Bentkover JD, et al. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 2004 Mar; 63(3): 461–5

    Article  PubMed  Google Scholar 

  7. Turner DA, Shaw C, McGrother CW, et al. The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU Int 2004 Jun; 93 (9): 1246–52

    Article  PubMed  CAS  Google Scholar 

  8. Abrams P, Andersson KE, Brubaker L, et al. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, et al., editors. Incontinence. Paris: Health Publication Ltd, 2005: 1589–630

    Google Scholar 

  9. Nygaard IE, Kreder KJ, Lepic MM, et al. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. Am J Obstet Gynecol 1996 Jan; 174 (1 Pt 1): 120–5

    Article  PubMed  CAS  Google Scholar 

  10. Hashim H, Abrams P. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations. Drugs 2004; 64(15): 1643–56

    Article  PubMed  CAS  Google Scholar 

  11. Andersson KE, Appell R, Cardozo L, et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, et al. editors. Incontinence. Paris: Health Publication Ltd, 2005: 809–54

    Google Scholar 

  12. Dmochowski RR, Sand PK, Zinner NR, et al. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003 Aug; 62(2): 237–42

    Article  PubMed  Google Scholar 

  13. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003 Jul; 189(1): 98–101

    Article  PubMed  Google Scholar 

  14. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003 Jul; 189(1): 98–101

    Article  PubMed  Google Scholar 

  15. Bump R, Yalcin I, Voss S. The effect of duloxetine dose escalation and tapering on the incidence of adverse events (AE) in women with stress urinary incontinence (SUI) [abstract no. 116]. Neurourol Urodyn 2005 Sep; 24(5/6): 582–3

    Google Scholar 

  16. Lilley Research Laboratories. Safety data on Cymbalta (duloxetine hydrochloride): hepatic effects. [online]. Available from URL: http://www.fda.gov/medwatch Accessed 2006 Sep 18]

  17. Khullar V, Hill S, Laval KU, et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology 2004 Aug; 64(2): 269–74

    Article  PubMed  Google Scholar 

  18. Kreder KJ, Brubaker L, Mainprize T. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int 2003 Sep; 92(4): 418–21

    Article  PubMed  CAS  Google Scholar 

  19. Dmochowski RR, Davila GW, Zinner NR, et al. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 2002 Aug; 168(2): 580–6

    Article  PubMed  CAS  Google Scholar 

  20. Kelleher C, Cardozo L, Kobashi K, et al. Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunt 2005 Nov; 8: 1–7

    Google Scholar 

  21. Cardozo L, Lose G, McClish D, et al. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 2004 Oct; 83(10): 892–7

    PubMed  Google Scholar 

  22. Robinson D, Cardozo L, Akeson M, et al. Antidiuresis: a new concept in managing female daytime urinary incontinence. BJU Int 2004 May; 93(7): 996–1000

    Article  PubMed  CAS  Google Scholar 

  23. Ishiko O, Ushiroyama T, Saji F, et al. β2-Adrenergic agonists and pelvic floor exercises for female stress incontinence. Int J Gynaecol Obstet 2000 Oct; 71(1): 39–44

    Article  PubMed  CAS  Google Scholar 

  24. Lin HH, Sheu BC, Lo MC, et al. Comparison of treatment outcomes for imipramine for female genuine stress incontinence. Br J Obstet Gynaecol 1999 Oct; 106(10): 1089–92

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Managing urinary incontinence in women depends on whether symptoms are associated with stress, urgency or both. Drugs Ther. Perspect 23, 10–13 (2007). https://doi.org/10.2165/00042310-200723010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200723010-00004

Search

Navigation